Use of hydroxy-methyl-glutaryl coenzyme A reductase inhibitors is associated with risk of lymphoid malignancies.
Iwata H, Matsuo K, Hara S, Takeuchi K, Aoyama T, Murashige N, Kanda Y, Mori S, Suzuki R, Tachibana S, Yamane M, Odawara M, Mutou Y, Kami M.
Iwata H, et al.
Cancer Sci. 2006 Feb;97(2):133-8. doi: 10.1111/j.1349-7006.2006.00153.x.
Cancer Sci. 2006.
PMID: 16441424
Free PMC article.